COVID-19 activates endogenous retroviruses within our genome

COVID-19 activates endogenous retroviruses within our genome

4.7
(436)
Write Review
More
$ 20.00
Add to Cart
In stock
Description

Researchers assess the impact of SARS-CoV-2 infection on endogenous retroviruses of the LTR69 subfamily.

Antiviral activity of the human endogenous retrovirus‐R envelope protein against SARS‐CoV‐2

Ankit Arora (@aarora396) / X

Impaired activation of transposable elements in SARS‐CoV‐2 infection

HERV-K group of endogenous retroviruses and cancer - Assay Genie

Frontiers Human Endogenous Retroviruses Are Ancient Acquired Elements Still Shaping Innate Immune Responses

Frontiers Retroviruses of the Human Virobiota: The Recycling of Viral Genes and the Resulting Advantages for Human Hosts During Evolution

JCI Insight - SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements

T-bet+ B cells are activated by and control endogenous retroviruses through TLR-dependent mechanisms

Human endogenous retrovirus expression as targets for multiple sclerosis